Concepts (140)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seizures | 17 | 2023 | 297 | 2.990 |
Why?
|
| Electroencephalography | 20 | 2023 | 709 | 2.890 |
Why?
|
| Anticonvulsants | 8 | 2017 | 126 | 2.020 |
Why?
|
| Epilepsy | 9 | 2023 | 397 | 1.780 |
Why?
|
| Critical Illness | 4 | 2023 | 294 | 1.050 |
Why?
|
| Triazines | 3 | 2011 | 53 | 0.760 |
Why?
|
| Neurophysiology | 3 | 2013 | 14 | 0.670 |
Why?
|
| Multicenter Studies as Topic | 3 | 2013 | 159 | 0.650 |
Why?
|
| Brain Injuries | 3 | 2021 | 161 | 0.620 |
Why?
|
| Monitoring, Physiologic | 7 | 2023 | 268 | 0.610 |
Why?
|
| Terminology as Topic | 3 | 2020 | 217 | 0.540 |
Why?
|
| Nervous System Diseases | 2 | 2006 | 151 | 0.520 |
Why?
|
| Brain Waves | 3 | 2018 | 32 | 0.450 |
Why?
|
| Benzodiazepines | 2 | 2008 | 65 | 0.410 |
Why?
|
| Piracetam | 2 | 2010 | 8 | 0.400 |
Why?
|
| Fructose | 2 | 2010 | 35 | 0.370 |
Why?
|
| Drug Resistance | 1 | 2010 | 256 | 0.340 |
Why?
|
| Neuroprotective Agents | 2 | 2006 | 94 | 0.330 |
Why?
|
| Electrodes, Implanted | 1 | 2009 | 171 | 0.330 |
Why?
|
| Status Epilepticus | 1 | 2008 | 31 | 0.320 |
Why?
|
| Humans | 35 | 2023 | 86643 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2008 | 236 | 0.290 |
Why?
|
| Emergency Medical Services | 1 | 2008 | 209 | 0.270 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 584 | 0.260 |
Why?
|
| Middle Aged | 16 | 2022 | 25028 | 0.260 |
Why?
|
| Retrospective Studies | 9 | 2021 | 8489 | 0.250 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2010 | 1961 | 0.240 |
Why?
|
| Intensive Care Units | 4 | 2020 | 373 | 0.240 |
Why?
|
| Brain | 4 | 2023 | 2216 | 0.230 |
Why?
|
| Aged | 12 | 2020 | 18415 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2006 | 371 | 0.220 |
Why?
|
| Male | 19 | 2020 | 40965 | 0.220 |
Why?
|
| Female | 19 | 2022 | 44532 | 0.220 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2021 | 12 | 0.190 |
Why?
|
| Adult | 11 | 2020 | 25648 | 0.190 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2023 | 247 | 0.190 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 6509 | 0.190 |
Why?
|
| Machine Learning | 2 | 2019 | 232 | 0.180 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 559 | 0.180 |
Why?
|
| Periodicity | 2 | 2018 | 119 | 0.180 |
Why?
|
| Myelitis, Transverse | 1 | 2007 | 10 | 0.150 |
Why?
|
| Patient Discharge | 1 | 2020 | 300 | 0.150 |
Why?
|
| Inpatients | 1 | 2020 | 297 | 0.150 |
Why?
|
| Length of Stay | 1 | 2020 | 702 | 0.150 |
Why?
|
| Tuberculosis, Spinal | 1 | 2006 | 1 | 0.150 |
Why?
|
| Myelitis | 1 | 2006 | 2 | 0.150 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2006 | 2 | 0.140 |
Why?
|
| Patient Readmission | 1 | 2020 | 329 | 0.140 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2018 | 86 | 0.140 |
Why?
|
| Adolescent | 5 | 2011 | 8981 | 0.140 |
Why?
|
| Risk Factors | 3 | 2020 | 5417 | 0.140 |
Why?
|
| Laughter | 1 | 2005 | 4 | 0.140 |
Why?
|
| Brain Stem Infarctions | 1 | 2005 | 5 | 0.130 |
Why?
|
| Pons | 1 | 2005 | 24 | 0.130 |
Why?
|
| Drug Therapy, Combination | 2 | 2008 | 894 | 0.130 |
Why?
|
| Patient Compliance | 1 | 2007 | 227 | 0.130 |
Why?
|
| Basilar Artery | 1 | 2005 | 41 | 0.130 |
Why?
|
| Affective Symptoms | 1 | 2005 | 47 | 0.130 |
Why?
|
| Delta Rhythm | 2 | 2017 | 19 | 0.130 |
Why?
|
| Age Factors | 2 | 2011 | 1851 | 0.130 |
Why?
|
| Intracranial Aneurysm | 1 | 2005 | 158 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 376 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2023 | 2705 | 0.110 |
Why?
|
| Tremor | 1 | 2011 | 22 | 0.100 |
Why?
|
| Postural Balance | 1 | 2011 | 42 | 0.100 |
Why?
|
| Sleep Stages | 1 | 2011 | 45 | 0.100 |
Why?
|
| Young Adult | 3 | 2019 | 5976 | 0.100 |
Why?
|
| Drug Interactions | 1 | 2011 | 248 | 0.100 |
Why?
|
| Prognosis | 3 | 2018 | 3679 | 0.100 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2010 | 17 | 0.090 |
Why?
|
| Phenytoin | 1 | 2010 | 16 | 0.090 |
Why?
|
| Amines | 1 | 2010 | 27 | 0.090 |
Why?
|
| Carbamazepine | 1 | 2010 | 10 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2020 | 2207 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 83 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2010 | 7993 | 0.090 |
Why?
|
| Barbiturates | 1 | 2008 | 12 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 201 | 0.080 |
Why?
|
| Outpatients | 1 | 2008 | 94 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2008 | 244 | 0.080 |
Why?
|
| Propofol | 1 | 2008 | 89 | 0.080 |
Why?
|
| Stroke | 1 | 2007 | 965 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2007 | 88 | 0.080 |
Why?
|
| Metabolic Clearance Rate | 1 | 2007 | 121 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2008 | 125 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2006 | 3362 | 0.070 |
Why?
|
| Antimanic Agents | 1 | 2006 | 11 | 0.070 |
Why?
|
| Odds Ratio | 1 | 2008 | 678 | 0.070 |
Why?
|
| Brain Mapping | 1 | 2009 | 548 | 0.070 |
Why?
|
| Drug Tolerance | 1 | 2006 | 63 | 0.070 |
Why?
|
| Expert Testimony | 1 | 2006 | 46 | 0.070 |
Why?
|
| Ambulatory Care | 1 | 2007 | 181 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1036 | 0.070 |
Why?
|
| Critical Care | 2 | 2019 | 370 | 0.060 |
Why?
|
| Logistic Models | 1 | 2008 | 1186 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 1673 | 0.060 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2006 | 199 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2018 | 1805 | 0.060 |
Why?
|
| Child | 2 | 2008 | 6927 | 0.050 |
Why?
|
| Proteomics | 1 | 2023 | 212 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 1991 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2019 | 2767 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 372 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2020 | 2261 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 582 | 0.050 |
Why?
|
| Homeostasis | 1 | 2023 | 409 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2023 | 187 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2023 | 349 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2006 | 1169 | 0.050 |
Why?
|
| Reference Standards | 1 | 2020 | 159 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 369 | 0.040 |
Why?
|
| Time Factors | 2 | 2020 | 5210 | 0.040 |
Why?
|
| Electrocorticography | 1 | 2018 | 37 | 0.040 |
Why?
|
| Inflammation | 1 | 2023 | 920 | 0.040 |
Why?
|
| Pakistan | 1 | 2007 | 15 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 1170 | 0.040 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 2232 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2007 | 194 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2016 | 216 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2016 | 307 | 0.030 |
Why?
|
| Pyramidal Tracts | 1 | 2005 | 16 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2005 | 45 | 0.030 |
Why?
|
| Acute Disease | 1 | 2007 | 826 | 0.030 |
Why?
|
| Aneurysm, False | 1 | 2005 | 54 | 0.030 |
Why?
|
| Deglutition | 1 | 2005 | 73 | 0.030 |
Why?
|
| Respiratory Center | 1 | 2005 | 53 | 0.030 |
Why?
|
| Amygdala | 1 | 2005 | 84 | 0.030 |
Why?
|
| Motivation | 1 | 2007 | 287 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1019 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 339 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2005 | 408 | 0.030 |
Why?
|
| Hospitalization | 1 | 2017 | 849 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2007 | 1621 | 0.030 |
Why?
|
| Atrial Fibrillation | 1 | 2005 | 288 | 0.030 |
Why?
|
| Research | 1 | 2012 | 253 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 602 | 0.020 |
Why?
|
| Mice | 1 | 2023 | 11352 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2017 | 4213 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 1830 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 26582 | 0.020 |
Why?
|